Background Image
Previous Page  127 / 156 Next Page
Information
Show Menu
Previous Page 127 / 156 Next Page
Page Background

125

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

1

Addeo R, Nocera V, Faiola V, Vincenzi B, Ferraro G, Montella L, Guarrasi R, Rossi E,

Cennamo G, Tonini G, Capasso E, Santini D, Caraglia M, Del Prete S. Management of pain

in elderly patients receiving infusion of zoledronic acid for bone metastasis: A single –

institution report. Supportive Care in Cancer 2008; 16 (2), 209 – 214.

2

Ajani JA, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor

M, Chao Y, Voznyi E, Marabotti C, Van Cutsem E; V-325 Study Group. Clinical benefit with

docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a

phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325

Study Group. J Clin Oncol 2007; 25(22): 3205-3209.

3

Amano E, Akamatsu T, Sonoda S, Konishi A, Shibuya H, Hirata T. [Study of analgestic effi-

cacy of ropivacaine-fentanyl patient-controlled epidural analgesia after upper abdominal

gynecological surgery]. Masui 2006; 55(9): 1149-1154.

4

Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of Venla-

faxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain 2010; 26(5):

381-385.

5

Anderson KO, Cohen MZ, Mendoza TR, Guo H, Harle MT, Cleeland CS. Brief cognitive-

behavioral audiotape interventions for cancer-related pain: Immediate but not long-term

effectiveness. Cancer 2006; 107(1): 207-214.

6

Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O. Influences

on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult

cancer patients. Eur J Clin Pharmacol 2011; 67(5): 493-506.

7

Anghelescu DL, Ross CE, Oakes LL, Burgoyne LL. The safety of concurrent administration

of opioids via epidural and intravenous routes for postoperative pain in pediatric oncolo-

gy patients. J Pain Symptom Manage 2008; 35(4): 412-419.

8

Anwendung von Bisphosphonaten bei Patienten mit Knochenmetastasen oder Multiplem

Myelom. Leitlinien der Deutschen Krebsgesellschaft, 2008.

9

Anwendung von Bisphosphonaten bei Patienten mit Knochenmetastasen oder Multiplem

Myelom. Leitlinien der Deutschen Krebsgesellschaft.

10

Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT; Cancer

Pain Outcome Research Study Group (CPOR SG) Investigators. Pattern and quality of

care of cancer pain management. Results from the Cancer Pain Outcome Research Study

Group. Br J Cancer 2009; 100(10): 1566-1574.

11

Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome

Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli

O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Effects of transder-

mal buprenorphine on patients-reported outcomes in cancer patients: results from the

Cancer Pain Outcome Research (CPOR) Study Group. Clin J Pain 2009; 25(8): 671-682.

12

Arai YC, Matsubara T, Shimo K, Suetomi K, Nishihara M, Ushida T, Kobayashi K, Suzuki

C, Kinoshita A, Kondo M, Matsubara S, Hayashi R, Tohyama Y, Nishida K, Arakawa M.

Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when

combined with low-dose imipramine. J Anesth 2010; 24(3): 407-410.

Literaturverzeichnis